We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

124 hedge funds and large institutions have $1.32B invested in Ironwood Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 46 increasing their positions, 39 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $6.05M | Put options by funds: $3.37M

18% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 39

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

1% more capital invested

Capital invested by funds: $1.32B → $1.32B (+$7.57M)

0% more funds holding

Funds holding: 124 → 124 (0)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
124
Holders Change
–
Holders Change %
0%
% of All Funds
3.6%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
15
Increased
46
Reduced
39
Closed
13
Calls
$6.05M
Puts
$3.37M
Net Calls
+$2.69M
Net Calls Change
+$1.23M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$18M
2
Deutsche Bank
Deutsche Bank
Germany
+$14.2M
3
TI
Turner Investments
Pennsylvania
+$10.4M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$9.25M
5
Wells Fargo
Wells Fargo
California
+$3.79M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$12.4M
2
Millennium Management
Millennium Management
New York
-$9.22M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.11M
4
CCP
Clough Capital Partners
Massachusetts
-$7.27M
5
CGT
Capital Guardian Trust
California
-$4.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$9.11M -$9.22M -1,027,536 -52%
TCM
27
Tekla Capital Management
Massachusetts
$8.92M – – –
SGA
28
Sector Gamma AS
Norway
$8.62M +$3.42M +380,886 +75%
CCP
29
Clough Capital Partners
Massachusetts
$7.73M -$7.27M -809,532 -50%
Axa
30
Axa
France
$7.16M +$230K +25,576 +4%
BBA
31
Baker Bros. Advisors
New York
$6.34M +$911K +101,490 +18%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$5.96M +$499K +55,568 +10%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$5.78M +$127K +14,196 +2%
Wells Fargo
34
Wells Fargo
California
$5.05M +$3.79M +422,438 +433%
TCIM
35
TIAA CREF Investment Management
New York
$4.5M +$142K +15,813 +4%
SAM
36
Senzar Asset Management
New York
$4.46M +$4.12M +458,735 New
Citadel Advisors
37
Citadel Advisors
Florida
$4.28M +$2.62M +291,814 +197%
SFM
38
Sphera Funds Management
Israel
$4M +$3.7M +411,930 New
NTCOC
39
Northern Trust Company of Connecticut
Connecticut
$3.75M +$671K +74,718 +24%
SEP
40
Sound Energy Partners
Connecticut
$3.58M +$2.38M +264,829 +257%
GC
41
Guggenheim Capital
Illinois
$3.46M -$206K -22,911 -6%
BA
42
BlackRock Advisors
Delaware
$3.24M +$55K +6,126 +2%
PAMU
43
Pictet Asset Management (UK)
United Kingdom
$3.15M +$263K +29,253 +10%
PRC
44
Platte River Capital
Colorado
$3.03M +$2.8M +311,383 New
BIM
45
BlackRock Investment Management
Delaware
$2.97M -$64.2K -7,149 -2%
Charles Schwab
46
Charles Schwab
California
$2.91M +$110K +12,224 +4%
AG
47
Artal Group
Luxembourg
$2.52M – – –
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$2.49M -$39.7K -4,418 -2%
KAH
49
Kathryn A. Hall
$2.25M – – –
BCB
50
Brian C. Broderick
$2.16M – – –
1
2
3 4 5

IRWD Hedge Fund Activity: Q4 2013 in Review

124 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2013, worth a combined $1.32B — up 0.58% from $1.32B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new IRWD positions and 13 closed out — a net gain of 2 holders — while 46 added to existing stakes and 39 trimmed.

The largest buyer was BVF Inc, adding an estimated $18M. The largest seller was Morgan Stanley, cutting an estimated $12.4M.

  • 124 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $1.32B of Ironwood Pharmaceuticals stock for Q4 2013, up 0.58% quarter-over-quarter.
  • 15 funds opened new Ironwood Pharmaceuticals positions in Q4 2013 and 13 closed out, a net change of +2 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q4 2013 was BVF Inc, an estimated $18M added.
  • The largest Ironwood Pharmaceuticals seller in Q4 2013 was Morgan Stanley, an estimated $12.4M sold.

Based on aggregated 13F filings for Q4 2013.